Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Central Nervous System"" wg kryterium: Temat


Tytuł :
Inflammatory Diseases of the Central Nervous System.
Autorzy :
Malani Shukla N; Department of Neurology and Developmental Neuroscience, Texas Children's Hospital, Baylor College of Medicine, 6701 Fannin Street, Suite 1250, Houston, TX 77030, USA. Electronic address: .
Lotze TE; Department of Neurology and Developmental Neuroscience, Texas Children's Hospital, Baylor College of Medicine, 6701 Fannin Street, Suite 1250, Houston, TX 77030, USA.
Muscal E; Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Co-appointment in Department of Neurology and Developmental Neuroscience, 6701 Fannin Street, 11th Floor, Houston, TX 77030, USA.
Pokaż więcej
Źródło :
Neurologic clinics [Neurol Clin] 2021 Aug; Vol. 39 (3), pp. 811-828. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Brain Diseases*
Central Nervous System Diseases*/diagnosis
Central Nervous System Diseases*/epidemiology
Central Nervous System Diseases*/therapy
Epilepsy*
Neurodegenerative Diseases*
Vasculitis, Central Nervous System*
Central Nervous System ; Child ; Humans ; Inflammation
Czasopismo naukowe
Tytuł :
Could the Possibility of Secondary Central Nervous System Lymphoma Be Ruled Out in This Patient?
Autorzy :
Kobayashi Z; Department of Neurology, JA Toride Medical Center, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Oct 01; Vol. 60 (19), pp. 3191. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Letter; Comment
MeSH Terms :
Central Nervous System Neoplasms*/diagnosis
Lymphoma*/diagnosis
Neoplasms, Second Primary*
Central Nervous System ; Humans
Opinia redakcyjna
Tytuł :
Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required.
Autorzy :
Martinez-Calle N; Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; School of Medicine, University of Nottingham, Nottingham, UK.
Wilson MR; Department of Haematology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Eyre TA; Department of Clinical Haematology, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
Cwynarski K; Department of Haematology, University College Hospital, London, UK.
McKay P; Department of Haematology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Fox CP; Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; School of Medicine, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2021 Sep 01; Vol. 96 (9), pp. E338-E339. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Letter; Comment
MeSH Terms :
Central Nervous System Neoplasms*/drug therapy
Central Nervous System Neoplasms*/prevention & control
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Central Nervous System ; Humans ; Methotrexate/adverse effects ; Neoplasm Recurrence, Local ; Retrospective Studies
Opinia redakcyjna
Tytuł :
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Autorzy :
Louis DN; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Perry A; Department of Pathology, University of California San Francisco, San Francisco, California, USA.
Wesseling P; Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, the Netherlands.; Laboratory for Childhood Cancer Pathology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Brat DJ; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Cree IA; International Agency for Research on Cancer, World Health Organization, Lyon, France.
Figarella-Branger D; Service d'Anatomie Pathologique et de Neuropathologie, APHM, CNRS, Institut de Neurophysiopathologie, Hôpital de la Timone, Aix-Marseille University, Marseille, France.
Hawkins C; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Ng HK; Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Hong Kong, China.
Pfister SM; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), and Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Reifenberger G; Institute of Neuropathology, University Hospital Düsseldorf and Medical Faculty, Heinrich Heine University Düsseldorf, and German Cancer Consortium (DKTK) Partner Site Essen/Düsseldorf, Düsseldorf, Germany.
Soffietti R; Department of Neurology and Neuro-Oncology, University of Turin Medical School, Turin, Italy.
von Deimling A; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany.
Ellison DW; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2021 Aug 02; Vol. 23 (8), pp. 1231-1251.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Central Nervous System Neoplasms*/diagnosis
Brain ; Central Nervous System ; Humans ; Pathology, Molecular ; World Health Organization
Czasopismo naukowe
Tytuł :
Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis.
Autorzy :
Matsuzono K; Division of Neurology, Department of Medicine, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Yagisawa T; Division of Neurology, Department of Medicine, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.; Department of Neurosurgery, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Ohtani K; Department of Neurosurgery, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Ishishita Y; Department of Neurosurgery, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Yamaguchi T; Department of Neurosurgery, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Mashiko T; Division of Neurology, Department of Medicine, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Ozawa T; Division of Neurology, Department of Medicine, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Koide R; Division of Neurology, Department of Medicine, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Tanaka R; Division of Neurology, Department of Medicine, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Kawai K; Department of Neurosurgery, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Fujimoto S; Division of Neurology, Department of Medicine, 12838Jichi Medical University, Jichi Medical University, Tochigi, Japan.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2021 Aug; Vol. 49 (8), pp. 3000605211035197.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Central Nervous System Neoplasms*/diagnostic imaging
Lymphoma*
Lymphoma, Non-Hodgkin*/diagnostic imaging
Aged ; Biopsy ; Brain/diagnostic imaging ; Central Nervous System ; Female ; Fluorodeoxyglucose F18 ; Humans ; Magnetic Resonance Imaging ; Positron-Emission Tomography ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Comment on "superficial siderosis of the central nervous system associated with ventral dural defects: bleeding from the epidural venous plexus".
Autorzy :
Andereggen L; Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland. .; Faculty of Medicine, University of Bern, Bern, Switzerland. .
Steiger HJ; Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.
Diepers M; Department of Neuroradiology, Kantonsspital Aarau, Aarau, Switzerland.
Marbacher S; Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.; Faculty of Medicine, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło :
Journal of neurology [J Neurol] 2021 Oct; Vol. 268 (10), pp. 3913-3915. Date of Electronic Publication: 2021 Jun 13.
Typ publikacji :
Letter
MeSH Terms :
Central Nervous System Diseases*
Siderosis*/complications
Siderosis*/diagnostic imaging
Subarachnoid Hemorrhage*
Central Nervous System ; Humans ; Magnetic Resonance Imaging
Opinia redakcyjna
Tytuł :
Reply to the Letter "Could the Possibility of Secondary Central Nervous System Lymphoma Be Ruled Out in This Patient?"
Autorzy :
Hirato T; Department of Neurology, Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Japan.
Komatsu K; Department of Neurology, Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Japan.
Nishida N; Department of Neurosurgery, Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Japan.
Matsumoto S; Department of Neurology, Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Oct 01; Vol. 60 (19), pp. 3193. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Letter; Comment
MeSH Terms :
Central Nervous System Neoplasms*/diagnosis
Lymphoma*/diagnosis
Neoplasms, Second Primary*
Central Nervous System ; Humans
Opinia redakcyjna
Tytuł :
Giant central nervous system tuberculoma in pediatric patients: surgical case series.
Autorzy :
Xiao X; Department of Neurosurgery, West China Hospital of Sichuan University, No. 37 Guoxue Road, Chengdu, 610041, Sichuan Province, People's Republic of China.
Li Q; Department of Neurosurgery, West China Hospital of Sichuan University, No. 37 Guoxue Road, Chengdu, 610041, Sichuan Province, People's Republic of China.
Ju Y; Department of Neurosurgery, West China Hospital of Sichuan University, No. 37 Guoxue Road, Chengdu, 610041, Sichuan Province, People's Republic of China. .
Pokaż więcej
Źródło :
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery [Childs Nerv Syst] 2021 Sep; Vol. 37 (9), pp. 2935-2941. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Tuberculoma*/diagnostic imaging
Tuberculoma*/surgery
Tuberculosis, Central Nervous System*
Adolescent ; Central Nervous System ; Child ; Child, Preschool ; Female ; Humans ; Magnetic Resonance Imaging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Nanomedicine Applications in Treatment of Primary Central Nervous System Lymphoma: Current State of the Art.
Autorzy :
Wang M; Department of Hematology and Research Laboratory of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Qu Y; Department of Hematology and Research Laboratory of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Hu D; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center, Chengdu, Sichuan, 610041, P. R. China.
Niu T; Department of Hematology and Research Laboratory of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Qian Z; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center, Chengdu, Sichuan, 610041, P. R. China.
Pokaż więcej
Źródło :
Journal of biomedical nanotechnology [J Biomed Nanotechnol] 2021 Aug 01; Vol. 17 (8), pp. 1459-1485.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Central Nervous System Neoplasms*/drug therapy
Lymphoma, Non-Hodgkin*
Blood-Brain Barrier ; Central Nervous System ; Humans ; Nanomedicine
Czasopismo naukowe
Tytuł :
[Clinical Efficacy of High Dose Methotrexate, Temozolomide and Rituximab in the Treatment of Patients with Primary Central Nervous System Lymphoma].
Autorzy :
Pang DW; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China.
Chen FL; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China.
Guo HG; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China.
Jiang XM; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China.
Wei XJ; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China.
Liu SC; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China.
Huang L; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China.
Liang ZL; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China.
Li WY; Department of Lymphoma Division, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou 510100, Guangdong Province, China E-mail: .
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Aug; Vol. 29 (4), pp. 1175-1180.
Typ publikacji :
Journal Article
MeSH Terms :
Central Nervous System Neoplasms*/drug therapy
Lymphoma, Non-Hodgkin*/drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Central Nervous System ; Humans ; Methotrexate/therapeutic use ; Retrospective Studies ; Rituximab/therapeutic use ; Temozolomide/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Letter to the Editor Regarding "Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years".
Autorzy :
Mathon B; Department of Neurosurgery, APHP-Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France; Sorbonne University, Paris Brain Institute, ICM, Paris, France. Electronic address: .
Marijon P; Department of Neurosurgery, APHP-Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France; Sorbonne University, Paris Brain Institute, ICM, Paris, France.
Riche M; Department of Neurosurgery, APHP-Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France.
Amelot A; Department of Neurosurgery, APHP-Sorbonne University, La Pitié-Salpêtrière Hospital, Paris, France; Department of Neurosurgery, Bretonneau Hospital, Tours, France.
Pokaż więcej
Corporate Authors :
PSL Brain-Biopsy Study Group
Źródło :
World neurosurgery [World Neurosurg] 2021 Aug; Vol. 152, pp. 242-243.
Typ publikacji :
Letter; Comment
MeSH Terms :
Central Nervous System Neoplasms*
Lymphoma*
Biopsy ; Central Nervous System ; Humans
Opinia redakcyjna
Tytuł :
In Reply to the Letter to the Editor Regarding "Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years".
Autorzy :
Maria Callovini G
Sherkat S
Gazzeri R
Telera S
Pokaż więcej
Źródło :
World neurosurgery [World Neurosurg] 2021 Aug; Vol. 152, pp. 244.
Typ publikacji :
Letter; Comment
MeSH Terms :
Central Nervous System Neoplasms*
Lymphoma*
Biopsy ; Central Nervous System ; Humans
Opinia redakcyjna
Tytuł :
Primary angiitis of the central nervous system mimicking a cerebellar tumor.
Autorzy :
Zhang G; Department of Neurosurgery, Yidu Central Hospital of Weifang, Qingzhou, China.
Yang C; Department of Neurosurgery, Yidu Central Hospital of Weifang, Qingzhou, China.
Chang J; Department of Hematology, Yidu Central Hospital of Weifang, Qingzhou, China.
Yuan X; Department of Neurosurgery, Yidu Central Hospital of Weifang, Qingzhou, China.
Bai Y; Department of Hematology, Yidu Central Hospital of Weifang, Qingzhou, China.
Niu J; Department of Neurology, Yidu Central Hospital of Weifang, Qingzhou, China.
Wang M; Department of Emergency, Affiliated Hospital of Weifang Medical University, Weifang city, China.
Pokaż więcej
Źródło :
British journal of neurosurgery [Br J Neurosurg] 2021 Jun; Vol. 35 (3), pp. 367-369. Date of Electronic Publication: 2018 Apr 14.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Cerebellar Neoplasms*/diagnostic imaging
Cerebellar Neoplasms*/surgery
Vasculitis, Central Nervous System*/diagnostic imaging
Vasculitis, Central Nervous System*/drug therapy
Central Nervous System ; Cerebellum/diagnostic imaging ; Humans
SCR Disease Name :
Primary angiitis of the central nervous system
Czasopismo naukowe
Tytuł :
Rituximab for refractory primary angiitis of the central nervous system: Experience in two patients.
Autorzy :
Paramasivan NK; Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. Electronic address: .
Sundaram S; Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. Electronic address: .
Sharma DP; Department of Imaging Sciences and Intervention Radiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. Electronic address: .
Sreedharan SE; Comprehensive Stroke Care Program, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. Electronic address: .
Sylaja PN; Comprehensive Stroke Care Program, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. Electronic address: .
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 Jun; Vol. 51, pp. 102907. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Vasculitis, Central Nervous System*/diagnostic imaging
Vasculitis, Central Nervous System*/drug therapy
Central Nervous System ; Cyclophosphamide/therapeutic use ; Humans ; Rituximab/therapeutic use
SCR Disease Name :
Primary angiitis of the central nervous system
Raport
Tytuł :
Prognostic models in primary central nervous system lymphoma patients: A systematic review.
Autorzy :
Jelicic J; Department of Haematology, Odense University Hospital, Odense, Denmark.
Stauffer Larsen T; Department of Haematology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Electronic address: .
Bukumiric Z; Department of Statistics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Juul-Jensen K; Department of Haematology, Odense University Hospital, Odense, Denmark.
Andjelic B; Department of Haematology, Blackpool Victoria Hospital, Lancashire Haematology Centre, Blackpool, United Kingdom.
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2021 May; Vol. 161, pp. 103341. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Central Nervous System Neoplasms*/diagnosis
Central Nervous System Neoplasms*/therapy
Lymphoma, Non-Hodgkin*
Central Nervous System ; Humans ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Autorzy :
Zayac AS; Lifespan Cancer Institute, Alpert Medical School of Brown University, Providence, RI.
Evens AM; Rutgers Cancer Institute of New Jersey, Robert Wood Johnson University Hospital, New Brunswick, NJ.
Danilov A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
Smith SD; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
Jagadeesh D; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Leslie LA; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Wei C; Rutgers Cancer Institute of New Jersey, Robert Wood Johnson University Hospital, New Brunswick, NJ.
Kim SH; Rush University Medical Center, Chicago, IL.
Naik S; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA.
Sundaram S; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Reddy N; Vanderbilt University Medical Center, Nashville, TN.
Farooq U; University of Iowa Carver College of Medicine, Iowa City, IA.
Kenkre VP; University of Wisconsin Carbone Cancer Center, Madison, WI.
Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Blum KA; Winship Cancer Institute, Emory University, Atlanta, GA.
Khan N; Fox Chase Cancer Center, Philadelphia, PA.
Singh D; Loyola University Medical Center, Loyola University Chicago, Maywood, IL.
Alderuccio JP; Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL.
Godara A; Tufts Medical Center, Boston, MA.
Yazdy MS; Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.
Diefenbach C; New York University School of Medicine, Perlmutter Cancer Center, New York, NY.
Rabinovich E; University of Illinois at Chicago, Chicago, IL.
Varma G; Weill Cornell Medical College, New York, NY.
Karmali R; Northwestern University, Chicago, IL.
Shao Y; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Trabolsi A; Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL.
Burkart M; Northwestern University, Chicago, IL.
Martin P; Weill Cornell Medical College, New York, NY.
Stettner S; University of Illinois at Chicago, Chicago, IL.
Chauhan A; Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.
Choi YK; New York University School of Medicine, Perlmutter Cancer Center, New York, NY.
Straker-Edwards A; Fox Chase Cancer Center, Philadelphia, PA.
Klein A; Tufts Medical Center, Boston, MA.
Churnetski MC; Winship Cancer Institute, Emory University, Atlanta, GA.
Boughan KM; University Hospitals Seidman Cancer Center, Cleveland, OH.
Berg S; Loyola University Medical Center, Loyola University Chicago, Maywood, IL.
Haverkos BM; University of Colorado Cancer Center, Aurora, CO.
Orellana-Noia VM; University of Virginia School of Medicine, Charlottesville, VA.
D'Angelo C; University of Wisconsin Carbone Cancer Center, Madison, WI.
Bond DA; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Maliske SM; University of Iowa Carver College of Medicine, Iowa City, IA.
Vaca R; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA.
Magarelli G; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Sperling A; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
Gordon MJ; Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
David KA; Rutgers Cancer Institute of New Jersey, Robert Wood Johnson University Hospital, New Brunswick, NJ.
Savani M; University of Minnesota, Minneapolis, MN.
Caimi P; University Hospitals Seidman Cancer Center, Cleveland, OH.
Kamdar M; University of Colorado Cancer Center, Aurora, CO.
Lunning MA; University of Nebraska Medical Center, Omaha, NE.
Palmisiano N; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Venugopal P; Rush University Medical Center, Chicago, IL.
Portell CA; University of Virginia School of Medicine, Charlottesville, VA.
Bachanova V; University of Minnesota, Minneapolis, MN.
Phillips T; University of Michigan, Ann Arbor, MI.
Lossos IS; Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL.
Olszewski AJ; Lifespan Cancer Institute, Alpert Medical School of Brown University, Providence, RI. .
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2021 Jul 01; Vol. 106 (7), pp. 1932-1942. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Burkitt Lymphoma*/diagnosis
Burkitt Lymphoma*/drug therapy
Burkitt Lymphoma*/epidemiology
Central Nervous System Neoplasms*/diagnosis
Central Nervous System Neoplasms*/drug therapy
Central Nervous System Neoplasms*/epidemiology
HIV Infections*
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Central Nervous System ; Cohort Studies ; Cyclophosphamide/therapeutic use ; Disease-Free Survival ; Doxorubicin/therapeutic use ; Humans ; Middle Aged ; Neoplasm Recurrence, Local ; Rituximab/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Autorzy :
Barajas RF; Department of Radiology, Neuroradiology Section, Oregon Health & Science University, Portland Oregon, USA.; Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon, USA.; Knight Cancer Institute Translational Oncology Program, Oregon Health & Science University, Portland, Oregon, USA.
Politi LS; Humanitas University and Humanitas Research and Clinical Center - IRCCS, Milan, Italy.; Boston Children's Hospital, Boston, Massachusetts, USA.
Anzalone N; Neuroradiology Unit, IRCCS San Raffaele Hospital and Vita-Salute University, Milan, Italy.
Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Fox CP; Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, School of Medicine, University of Nottingham, Nottingham, UK.
Boxerman JL; Department of Diagnostic Imaging, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
Kaufmann TJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Quarles CC; Department of Neuroimaging Research & Barrow Neuroimaging Innovation Center, Barrow Neurological Institute, Phoenix, Arizona, USA.
Ellingson BM; UCLA Brain Tumor Imaging Laboratory (BTIL), Departments of Radiological Sciences and Psychiatry, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California, USA.; Departments of Radiological Sciences, Psychiatry, and Biobehavioral Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California, USA.
Auer D; Versus Arthritis Pain Centre, University of Nottingham, Nottingham, UK.; NIHR Nottingham Biomedical Research Centre, Queen's Medical Centre, University of Nottingham, Nottingham, UK.; Sir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Andronesi OC; A. A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Ferreri AJM; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Mrugala MM; Department of Medicine, Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, Arizona, USA.; Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.
Grommes C; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Neurology, Weill Cornell Medical School, New York, New York, USA.
Neuwelt EA; Blood-Brain Barrier Program, Oregon Health & Science University, Portland, Oregon, USA.; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.; Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA.; Portland Veterans Affairs Medical Center, Portland, Oregon, USA.
Ambady P; Blood-Brain Barrier Program, Oregon Health & Science University, Portland, Oregon, USA.; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.
Rubenstein JL; Division of Hematology/Oncology, University of California, San Francisco, California, USA.; Department of Medicine, University of California, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
Illerhaus G; Clinic of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.
Nagane M; Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo, Japan.
Batchelor TT; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Hu LS; Department of Radiology, Neuroradiology Division, Mayo Clinic, Phoenix, Arizona, USA.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2021 Jul 01; Vol. 23 (7), pp. 1056-1071.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Central Nervous System Neoplasms*/diagnostic imaging
Lymphoma*/diagnostic imaging
Central Nervous System ; Consensus ; Humans ; Magnetic Resonance Imaging ; Positron-Emission Tomography ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Comparing the Pfizer Central Nervous System Multiparameter Optimization Calculator and a BBB Machine Learning Model.
Autorzy :
Urbina F; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7545, United States.; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States.
Zorn KM; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States.
Brunner D; PsychoGenics, 215 College Road, Paramus, New Jersey 07652, United States.
Ekins S; Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States.
Pokaż więcej
Źródło :
ACS chemical neuroscience [ACS Chem Neurosci] 2021 Jun 16; Vol. 12 (12), pp. 2247-2253. Date of Electronic Publication: 2021 May 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood-Brain Barrier*
Central Nervous System*
Bayes Theorem ; Central Nervous System Agents ; Machine Learning
Czasopismo naukowe
Tytuł :
Primary Central Nervous System Lymphoma Mimicking Wernicke's Encephalopathy.
Autorzy :
Wu L; Department of Neurology, the 1st Medical Center of Chinese PLA General Hospital, Beijing, China.
Jin D; Department of Neurology, Aerospace Center Hospital, Beijing, China.
Huang D; Department of Neurology, the 1st Medical Center of Chinese PLA General Hospital, Beijing, China.
Yu S; Department of Neurology, the 1st Medical Center of Chinese PLA General Hospital, Beijing, China.
Pokaż więcej
Źródło :
Neurology India [Neurol India] 2021 May-Jun; Vol. 69 (3), pp. 740-743.
Typ publikacji :
Case Reports
MeSH Terms :
Central Nervous System Neoplasms*/diagnostic imaging
Central Nervous System Neoplasms*/drug therapy
Lymphoma, Non-Hodgkin*
Wernicke Encephalopathy*/diagnostic imaging
Wernicke Encephalopathy*/drug therapy
Adult ; Central Nervous System ; Fluorodeoxyglucose F18 ; Humans ; Male
Raport
Tytuł :
Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma.
Autorzy :
Isaev K; Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada.
Ennishi D; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Hilton L; Simon Fraser University, Burnaby, BC, Canada.
Skinnider B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Mungall KL; Canada Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Mungall AJ; Canada Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Bakhtiari M; Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada.
Tremblay-LeMay R; Laboratory Medicine Program - University Health Network, Toronto, ON, Canada.
Silva A; Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada.
Ben-Neriah S; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Boyle M; BC Cancer.
Villa D; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Marra MA; Canada Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Steidl C; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Gascoyne RD; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Morin R; Simon Fraser University, Burnaby, BC, Canada.
Savage KJ; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Kridel R; Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2021 May 01; Vol. 106 (5), pp. 1466-1471. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Central Nervous System Neoplasms*/diagnosis
Central Nervous System Neoplasms*/drug therapy
Central Nervous System Neoplasms*/genetics
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Central Nervous System ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Rituximab/therapeutic use
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies